Uropharmacology in primary care: 2010 update.
Many disorders such as erectile dysfunction, overactive bladder, hypogonadism and benign prostatic hypertrophy have traditionally been managed primarily by urologists. The development of newer agents to treat many of these conditions has allowed the primary care provider to manage many of these common conditions. The use of these newer medications has become commonplace in the primary care setting. This article will update some of the most commonly used urologic medications to optimize patient management strategies by the primary care provider or in coordination with the urologist.
Gomella
Leonard G
LG
Department of Urology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.
Lallas
Costas D
CD
Perkel
Robert
R
Folia
Christine
C
Hirsch
Irvin
I
Das
Akhil
A
Shenot
Patrick
P
D007172:Erectile Dysfunction / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D005544:Forecasting; D006801:Humans; D007006:Hypogonadism / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D004364:Pharmaceutical Preparations / Q000008:administration & dosage; D010821:Physicians, Family / Q000639:trends; D011320:Primary Health Care / Q000379:methods* / Q000639:trends; D011470:Prostatic Hyperplasia / Q000175:diagnosis / Q000188:drug therapy; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000188:drug therapy; D053201:Urinary Bladder, Overactive / Q000175:diagnosis / Q000188:drug therapy; D014570:Urologic Diseases / Q000175:diagnosis* / Q000188:drug therapy*
D004364:Pharmaceutical Preparations